Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 07, 2023

SELL
$7.95 - $9.48 $179,670 - $214,248
-22,600 Reduced 80.43%
5,500 $3,000
Q3 2022

Oct 25, 2022

SELL
$6.86 - $11.95 $294,294 - $512,654
-42,900 Reduced 60.42%
28,100 $46,000
Q2 2022

Aug 04, 2022

SELL
$7.38 - $10.4 $353,502 - $498,160
-47,900 Reduced 40.29%
71,000 $106,000
Q1 2022

Apr 14, 2022

BUY
$7.33 - $9.39 $871,537 - $1.12 Million
118,900 New
118,900 $51,000
Q3 2021

Oct 26, 2021

SELL
$8.38 - $10.18 $10,894 - $13,234
-1,300 Closed
0 $0
Q2 2021

Jul 19, 2021

BUY
$9.9 - $11.56 $12,870 - $15,028
1,300 New
1,300 $0
Q1 2021

Apr 26, 2021

SELL
$10.34 - $12.81 $155,100 - $192,150
-15,000 Closed
0 $0
Q2 2020

Jul 22, 2020

SELL
$8.12 - $13.12 $91,755 - $148,256
-11,300 Reduced 42.97%
15,000 $14,000
Q1 2020

May 07, 2020

BUY
$6.69 - $13.45 $62,217 - $125,085
9,300 Added 54.71%
26,300 $63,000
Q2 2019

Aug 09, 2019

BUY
$8.12 - $15.72 $121,799 - $235,800
15,000 Added 750.0%
17,000 $64,000
Q1 2019

May 10, 2019

SELL
$15.58 - $20.01 $32,718 - $42,021
-2,100 Reduced 51.22%
2,000 $9,000
Q3 2018

Nov 07, 2018

BUY
$21.06 - $25.65 $84,240 - $102,600
4,000 Added 4000.0%
4,100 $7,000
Q1 2018

May 11, 2018

SELL
$16.68 - $22.07 $962,436 - $1.27 Million
-57,700 Reduced 99.83%
100 $1,000
Q4 2017

Jan 17, 2018

SELL
$11.23 - $19.1 $267,274 - $454,580
-23,800 Reduced 29.17%
57,800 $340,000
Q3 2017

Oct 17, 2017

BUY
$15.41 - $32.17 $1.26 Million - $2.63 Million
81,600
81,600 $685,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.